Correlation Between VanEck Pharmaceutical and Fidelity MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VanEck Pharmaceutical and Fidelity MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VanEck Pharmaceutical and Fidelity MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VanEck Pharmaceutical ETF and Fidelity MSCI Consumer, you can compare the effects of market volatilities on VanEck Pharmaceutical and Fidelity MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VanEck Pharmaceutical with a short position of Fidelity MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of VanEck Pharmaceutical and Fidelity MSCI.

Diversification Opportunities for VanEck Pharmaceutical and Fidelity MSCI

-0.88
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between VanEck and Fidelity is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding VanEck Pharmaceutical ETF and Fidelity MSCI Consumer in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fidelity MSCI Consumer and VanEck Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VanEck Pharmaceutical ETF are associated (or correlated) with Fidelity MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fidelity MSCI Consumer has no effect on the direction of VanEck Pharmaceutical i.e., VanEck Pharmaceutical and Fidelity MSCI go up and down completely randomly.

Pair Corralation between VanEck Pharmaceutical and Fidelity MSCI

Considering the 90-day investment horizon VanEck Pharmaceutical ETF is expected to under-perform the Fidelity MSCI. But the etf apears to be less risky and, when comparing its historical volatility, VanEck Pharmaceutical ETF is 1.36 times less risky than Fidelity MSCI. The etf trades about -0.2 of its potential returns per unit of risk. The Fidelity MSCI Consumer is currently generating about 0.32 of returns per unit of risk over similar time horizon. If you would invest  8,804  in Fidelity MSCI Consumer on August 26, 2024 and sell it today you would earn a total of  763.00  from holding Fidelity MSCI Consumer or generate 8.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

VanEck Pharmaceutical ETF  vs.  Fidelity MSCI Consumer

 Performance 
       Timeline  
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.
Fidelity MSCI Consumer 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Fidelity MSCI Consumer are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent forward indicators, Fidelity MSCI unveiled solid returns over the last few months and may actually be approaching a breakup point.

VanEck Pharmaceutical and Fidelity MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VanEck Pharmaceutical and Fidelity MSCI

The main advantage of trading using opposite VanEck Pharmaceutical and Fidelity MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VanEck Pharmaceutical position performs unexpectedly, Fidelity MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fidelity MSCI will offset losses from the drop in Fidelity MSCI's long position.
The idea behind VanEck Pharmaceutical ETF and Fidelity MSCI Consumer pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios